Brief: The9 Investee Nanyang Biologics (Nyb) Advancing Planned Nasdaq Listing For The $1.5 Billion Business Combination
11/08/2026 14:24
BRIEF-The9 Investee Nanyang Biologics (Nyb) Advancing Planned Nasdaq Listing For The $1.5 Billion Business Combination Aug 11 (Reuters) - The9 Ltd NCTY.O:
THE9 INVESTEE NANYANG BIOLOGICS (NYB) ADVANCING PLANNED NASDAQ LISTING FOR THE US$1.5 BILLION BUSINESS COMBINATION
THE9 - EXPECTS TO OWN 15%-16% OF COMBINED COMPANY AFTER NYB LISTING
THE9 - NASDAQ LISTING SUBJECT TO SPAC MEETING ON AUG 19, 2026 AND NASDAQ APPROVAL
Source text: ID:nPn5nXV5Na
Further company coverage: NCTY.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on The9
See all newsBrief: The9 Investee Nanyang Biologics (Nyb) Advancing Planned Nasdaq Listing For The $1.5 Billion Business Combination
NASDAQ RESUMED AT 09:40 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:35 AM
Brief: The9 Establishes Joint Venture To Focus On Mobile Game Operation And Distribution In China's Sinking Market
Brief: Shanghai The9 Information Technology Signs JV Agreement With Shenzhen Jituo Interactive Technology